More on CYTK

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-45.5% Growth)
- Ratings (9.2 Score)
- Holders

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (7/30/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

CYTK Cash Flow Statement

Click line-items for a historical chart and %
Net loss
Depreciation and amortization of property and equipment 517K
Loss on disposal of equipment 1K
Non-cash impairment charges
Non-cash restructuring expenses, net of reversals
Non-cash interest expense 395K
Non-cash forgiveness of loans to officers
Stock-based compensation 5.27M
Non-cash warrant expense
Other non-cash expenses
Related party accounts receivable -66.99M
Prepaid and other assets -922K
Accounts payable -1.33M
Accrued liabilities 9.12M
Related party payables and accrued liabilities
Deferred revenue 5.28M
Net cash used in operating activities
Purchases of investments -79.97M
Proceeds from sales and maturities of investments 70.57M
Proceeds from sales of auction rate securities
Purchases of property and equipment -742K
Proceeds from sales of property and equipment 33K
(Increase) decrease in restricted cash
Issuance of related party notes receivable
Proceeds from repayments of notes receivable
Net cash provided by (used in) investing activities
Proceeds from initial public offering, sale of common stock to related party, and public offerings, net of issuance costs
Proceeds from draw down of committed equity financing and at-the-market facility, net of issuance costs
Proceeds from other issuances of common stock and warrants, net of issuance costs
Proceeds from issuance of preferred stock, net of issuance costs
Repurchase of common stock
Proceeds from loan with UBS
Repayment of loan with UBS
Proceeds from equipment financing lines
Repayment of equipment financing lines
Net cash provided by (used in) financing activities
Net increase (decrease) in cash and cash equivalents -34.78M
Cash and cash equivalents, beginning of period 65.08M
Cash and cash equivalents, end of period 30.3M